Good agreements between self and clinician-collected specimens for the detection of human papillomavirus in Brazilian patients

• Autor(a) principal: Campos, Karla Lopes Mandu de
• Data de Publicação: 2014
• Outros Autores: Machado, Ana Paula, Almeida, Flávia Gatto de, Bonin, Camila Mareti, Prata, Thiago Theodoro Martins, Almeida, Larissa Zatorre, Padovani, Cacilda Tezelli Junqueira, Ferreira, Alda Maria Teixeira, Fernandes, Carlos Eurico dos Santos, Tozetti, Inês Aparecida
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFMS
• Texto Completo: https://repositorio.ufms.br/handle/123456789/2109; http://dx.doi.org/10.1590/0074-0276130397
• topic: Infecções por Papillomavirus; Neoplasias do Colo do Útero; Papillomavirus Infections; Uterine Cervical Neoplasms

ABSTRACT - Women infected with human papillomavirus (HPV) are at a higher risk of developing cervical lesions. In the current study, self and clinician-collected vaginal and cervical samples from women were processed to detect HPV DNA using polymerase chain reaction (PCR) with PGMY09/11 primers. HPV genotypes were determined using type-specific PCR. HPV DNA detection showed good concordance between self and clinician-collected samples (84.6%; kappa = 0.72). HPV infection was found in 30% women and genotyping was more concordant among high-risk HPV (HR-HPV) than low-risk HPV (HR-HPV). HPV16 was the most frequently detected among the HR-HPV types. LR-HPV was detected at a higher frequency in self-collected; however, HR-HPV types were more frequently identified in clinician-collected samples than in self-collected samples. HPV infections of multiple types were detected in 20.5% of clinician-collected samples and 15.5% of self-collected samples. In this study, we demonstrated that the HPV DNA detection rate in self-collected samples has good agreement with that of clinician-collected samples. Self-collected sampling, as a primary prevention strategy in countries with few resources, could be effective for identifying cases of HR-HPV, being more acceptable. The use of this method would enhance the coverage of screening programs for cervical cancer.